Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2018 ASCO Annual Meeting
23rd Congress of EHA
AUA 2018
ASBrS 2018
AACR Annual Meeting 2018
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
View All
Videos
Newsreels
Biosimilars Roundtable
Earn CME
Methotrexate–Induced Kidney Injury
Subscribe
Advertisement
Advertisement
2013 International Symposium on Hodgkin Lymphoma
«
1
»
Advertisement
Advertisement
Jun
25
Today In Oncology
FDA Grants Priority Review to Expanded Use of Gardasil 9 in Women and Men Aged 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases
Statement From FDA Commissioner on Agency Efforts to Advance the Patient Voice in Medical Product Development and Regulatory Decision-Making
AMA Plans Advocacy Outreach to Expand Colorectal Screening
Ibrutinib in Relapsed or Refractory Follicular Lymphoma
Suboptimal Use of Initial Chemotherapy in Newly Diagnosed AML
View More
;
Advertisement
Most Read Stories
Once- vs Twice-Weekly Carfilzomib in Relapsed or Refractory Multiple Myeloma
Eating a High-Quality Diet Could Decrease Cancer Survivors’ Risk of Death by 65%
Suboptimal Use of Initial Chemotherapy in Newly Diagnosed AML
FDA Grants Priority Review to Expanded Use of Gardasil 9 in Women and Men Aged 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases
2018 ASCO: Adjuvant mFOLFIRINOX vs Gemcitabine in Resected Pancreatic Cancer
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.
